The Newly Combined Axcan Pharma (AXCA) and Eurand Announce Name Change to Aptalis
5/6/2011 6:49:39 AM
More...
|
Axcan Pharma (AXCA) to Buy Mpex Pharmaceuticals, Inc. for Phase III-Stage Aerosol Antibiotic; Mpex Plans to Spin Out the Aeroquin Assets into a New Company
4/14/2011 10:55:47 AM
More...
|
Pinnacle Biologics Acquires PHOTOFRIN(R) and PHOTOBARR(R), Novel Photodynamic Therapy for Treating Various Types of Cancer
3/29/2011 8:34:23 AM
More...
|
Axcan Pharma (AXCA) Completes Acquisition of Eurand and Commences Subsequent Offering Period
2/11/2011 10:16:40 AM
More...
|
Eurand and Axcan Pharma (AXCA) Announce Extension of the Tender Offer
2/1/2011 8:33:50 AM
More...
|
Axcan Pharma (AXCA) Announces Proposed Private Offering of $225 Million of Senior Secured Notes and Intent to Amend and Restate Credit Facility
1/26/2011 10:27:24 AM
More...
|
Axcan Pharma (AXCA) Achieves Cost Savings with Medidata Solutions, Inc. Rave
6/2/2010 10:47:55 AM
More...
|
Axcan Pharma (AXCA) Presents PYLERA(R)'s European Phase III Trial Results at DDW 2010
4/28/2010 10:51:42 AM
More...
|
Leading Canadian Pharmaceutical Company Axcan Pharma (AXCA) Selects Emtec, Inc. Subsidiary to Provide Value Based Management Services
3/9/2010 9:46:32 AM
More...
|
AGI Therapeutics plc Announces Termination of Agreement With Axcan Pharma (AXCA) for AGI-010
8/14/2009 6:48:31 AM
More...
|
|